These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14762493)

  • 1. Ecstasy intoxication: the toxicological basis for treatment.
    Ferigolo M; Machado AG; Oliveira NB; Barros HM
    Rev Hosp Clin Fac Med Sao Paulo; 2003; 58(6):332-41. PubMed ID: 14762493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of acute psychotic episode after a single dose of ecstasy].
    Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
    Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ecstasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome.
    Demirkiran M; Jankovic J; Dean JM
    Clin Neuropharmacol; 1996 Apr; 19(2):157-64. PubMed ID: 8777769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute and long-term effects of ecstasy].
    Salzmann J; Marie-Claire C; Noble F
    Presse Med; 2004 Oct; 33(18 Suppl):24-32. PubMed ID: 15617173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agony and ecstasy: a review of MDMA effects and toxicity.
    Burgess C; O'Donohoe A; Gill M
    Eur Psychiatry; 2000 Aug; 15(5):287-94. PubMed ID: 10954872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ecstasy].
    Trkulja V; Lacković Z
    Lijec Vjesn; 1997; 119(5-6):158-66. PubMed ID: 9379824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered states: the clinical effects of Ecstasy.
    Cole JC; Sumnall HR
    Pharmacol Ther; 2003 Apr; 98(1):35-58. PubMed ID: 12667887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [History, effects and mechanisms of action of ecstasy (3,4-methylenedioxyamphetamine): review of the literature].
    de Almeida SP; Silva MT
    Rev Panam Salud Publica; 2000 Dec; 8(6):393-402. PubMed ID: 11209252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The many faces of ecstasy.
    Doyon S
    Curr Opin Pediatr; 2001 Apr; 13(2):170-6. PubMed ID: 11317061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
    Gouzoulis-Mayfrank E; Daumann J
    J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E; Daumann J
    Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA).
    Gouzoulis-Mayfrank E; Daumann J; Tuchtenhagen F; Pelz S; Becker S; Kunert HJ; Fimm B; Sass H
    J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):719-25. PubMed ID: 10811694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does hyperthyroidism increase risk of death due to the ingestion of ecstasy?
    Martin TL; Chiasson DA; Kish SJ
    J Forensic Sci; 2007 Jul; 52(4):951-3. PubMed ID: 17524054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
    Daumann J; Till B; Fischermann T; Rezk M; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2006 Mar; 20(2):236-44. PubMed ID: 16510481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.
    Buchert R; Obrocki J; Thomasius R; Väterlein O; Petersen K; Jenicke L; Bohuslavizki KH; Clausen M
    Nucl Med Commun; 2001 Aug; 22(8):889-97. PubMed ID: 11473208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').
    McCann UD; Slate SO; Ricaurte GA
    Drug Saf; 1996 Aug; 15(2):107-15. PubMed ID: 8884162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and dopamine in ecstasy users.
    Stuerenburg HJ; Petersen K; Bäumer T; Rosenkranz M; Buhmann C; Thomasius R
    Neuro Endocrinol Lett; 2002 Jun; 23(3):259-61. PubMed ID: 12080289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Death by "ecstasy": the serotonin syndrome?
    Mueller PD; Korey WS
    Ann Emerg Med; 1998 Sep; 32(3 Pt 1):377-80. PubMed ID: 9737504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.